DNA (Ginkgo Bioworks) חוב לטווח קצר של החברה

Due to its broad market reach spanning from the agricultural sector to chemicals, Ginkgo Bioworks Holdings (DNA) is shielded from industry shocks, although it is currently struggling with declining margins due to capacity expansion costs. This market valuation chart on GURU.Markets shows that the separate_debt_short metric is 0.00. The company's cloud services are blurring the lines in biodesign, providing reliable remote development for innovations.

Short-term debt reflects the total liabilities of a company with a maturity of up to one year. By analyzing short-term borrowed capital, an investor assesses liquidity and default risk. This metric aggregates current loans and accrued interest, determining the burden on current assets. For Ginkgo Bioworks Holdings (DNA), this serves as an indicator of resilience while scaling its AI platform. Managing these liabilities ensures the seamless execution of strategic alliances with pharmaceutical behemoths.